Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Marguello, MG"'
Autor:
Knoester, Marjolein, Helfferich, J, Poelman, Randy, Van Leer-Buter, Coretta, Brouwer, OF, Niesters, Hubert G.M., Aberle, SW, Popow-Kraupp, T, Nikolaeva-Glomb, L, Rainetova, P, Midgley, Sofie, Fischer, T.K., Simonlatser, G, Savolainen-Kopra, Carita, Lina, Bruno, Shuffenecker, I, Kossorotoff, M, Antona, D, Eis-Hübinger, Anna M., Buderus, S, Panning, Marcus, Nowotny, Marlene, Kiechle, L, Böttcher, S, Takács, Monika, Farkas, Árpád, Love, A, Baldanti, Fausto, Piralla, Antonio, Capobianchi, Maria R, Valli, Mats, Esposito, S, Pariani, E, Binda, S, Neuteboom, R, Pas, Suzan D., Benschop, Kimberley, Meijer, A, Nordbø, SA, Hafström, Maria, Dudman, Susanne Gjeruldsen, Pfeiffer, H, Guiomar, R, Palminha, P, Costa, I, Dias, Assembayev, Tecu, C, Cherciu, CM, Lazarevic, Ivana, Filipovic-Vignjevic, S, Berginc, Natasa, Marguello, MG, Cabrerizo, Maria, Garcia-Iniguez, JP, Perez-Castro, S, Rodrigo, CP, Antón, Annie, Rabella, N, Dyrdak, Robert, Albert, J, Kramer, R.B.G., Stacpoole, S, Thomas, R, O'Flaherty, N, Drew, RA, Templeton, K, McDougall, Craig, Eunson, Paul, Chinchankar, N, Shetty, J, Moore, Catherine, Williams, C
Externí odkaz:
http://hdl.handle.net/11250/2588203
Autor:
Estebanez EB; Management of primary health care centers, Area I, Area II, Area III and Area IV, Servicio Cantabro de Salud, C. Vargas 57, 39010, Santander, Cantabria, Spain., Alconero LL; Marqués de Valdecilla Research Institute (IDIVAL), s/n, Calle Cardenal Herrera Oria, 39012, Santander, Cantabria, Spain. lucialavinalconero@gmail.com.; Clinical Trials Agency Valdecilla-IDIVAL, Marqués de Valdecilla University Hospital, Av. Valdecilla, 25, 39008, Santander, Cantabria, Spain. lucialavinalconero@gmail.com., Fernández BJ; Management of primary health care centers, Area I, Area II, Area III and Area IV, Servicio Cantabro de Salud, C. Vargas 57, 39010, Santander, Cantabria, Spain., Marguello MG; Marqués de Valdecilla Research Institute (IDIVAL), s/n, Calle Cardenal Herrera Oria, 39012, Santander, Cantabria, Spain.; Department of Microbiology, Marqués de Valdecilla University Hospital, Av. Valdecilla, 25, 39008, Santander, Cantabria, Spain., Caro JCL; Management of primary health care centers, Area I, Area II, Area III and Area IV, Servicio Cantabro de Salud, C. Vargas 57, 39010, Santander, Cantabria, Spain., Vallejo JD; Management of primary health care centers, Area I, Area II, Area III and Area IV, Servicio Cantabro de Salud, C. Vargas 57, 39010, Santander, Cantabria, Spain., Sampedro MF; Marqués de Valdecilla Research Institute (IDIVAL), s/n, Calle Cardenal Herrera Oria, 39012, Santander, Cantabria, Spain.; Department of Infectious Diseases, Marqués de Valdecilla University Hospital, Av. Valdecilla, 25, 39008, Santander, Cantabria, Spain., Cacho PM; Marqués de Valdecilla Research Institute (IDIVAL), s/n, Calle Cardenal Herrera Oria, 39012, Santander, Cantabria, Spain.; Department of Community Health, Servicio Cantabro de Salud, C. Luis Vicente de Velasco 1, 39011, Santander, Cantabria, Spain., Espiga CR; Marqués de Valdecilla Research Institute (IDIVAL), s/n, Calle Cardenal Herrera Oria, 39012, Santander, Cantabria, Spain.; Emeritus Doctor, Department of Hematology, Marqués de Valdecilla University Hospital, Av. Valdecilla, 25, 39008, Santander, Cantabria, Spain., Saiz MMG; Marqués de Valdecilla Research Institute (IDIVAL), s/n, Calle Cardenal Herrera Oria, 39012, Santander, Cantabria, Spain.; Clinical Trials Agency Valdecilla-IDIVAL, Marqués de Valdecilla University Hospital, Av. Valdecilla, 25, 39008, Santander, Cantabria, Spain.; Department of Clinical Pharmacology, Marqués de Valdecilla University Hospital, Av. Valdecilla, 25, 39008, Santander, Cantabria, Spain.
Publikováno v:
Trials [Trials] 2021 Sep 06; Vol. 22 (1), pp. 590. Date of Electronic Publication: 2021 Sep 06.
